Madrigal Income Tax Expense vs Total Other Income Expense Net Analysis

MDGL Stock  USD 312.00  1.13  0.36%   
Madrigal Pharmaceuticals financial indicator trend analysis is infinitely more than just investigating Madrigal Pharmaceuticals recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Madrigal Pharmaceuticals is a good investment. Please check the relationship between Madrigal Pharmaceuticals Income Tax Expense and its Total Other Income Expense Net accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Madrigal Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
For more information on how to buy Madrigal Stock please use our How to buy in Madrigal Stock guide.

Income Tax Expense vs Total Other Income Expense Net

Income Tax Expense vs Total Other Income Expense Net Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Madrigal Pharmaceuticals Income Tax Expense account and Total Other Income Expense Net. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Madrigal Pharmaceuticals' Income Tax Expense and Total Other Income Expense Net is -0.23. Overlapping area represents the amount of variation of Income Tax Expense that can explain the historical movement of Total Other Income Expense Net in the same time period over historical financial statements of Madrigal Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of Madrigal Pharmaceuticals' Income Tax Expense and Total Other Income Expense Net is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Income Tax Expense of Madrigal Pharmaceuticals are associated (or correlated) with its Total Other Income Expense Net. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Other Income Expense Net has no effect on the direction of Income Tax Expense i.e., Madrigal Pharmaceuticals' Income Tax Expense and Total Other Income Expense Net go up and down completely randomly.

Correlation Coefficient

-0.23
Relationship DirectionNegative 
Relationship StrengthInsignificant

Income Tax Expense

Total Other Income Expense Net

Most indicators from Madrigal Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Madrigal Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Madrigal Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
For more information on how to buy Madrigal Stock please use our How to buy in Madrigal Stock guide.At this time, Madrigal Pharmaceuticals' Selling General Administrative is quite stable compared to the past year. Sales General And Administrative To Revenue is expected to rise to 75.06 this year, although Enterprise Value Over EBITDA will most likely fall to (12.00).

Madrigal Pharmaceuticals fundamental ratios Correlations

0.95-0.360.890.820.76-0.360.750.720.32-0.34-0.2-0.590.690.420.180.471.00.930.780.321.00.70.74-0.47-0.32
0.95-0.410.860.620.52-0.410.530.480.18-0.34-0.35-0.330.450.50.030.430.950.920.60.180.940.470.5-0.52-0.31
-0.36-0.41-0.580.06-0.131.0-0.22-0.15-0.24-0.220.29-0.24-0.18-0.31-0.06-0.23-0.39-0.32-0.16-0.24-0.39-0.04-0.110.82-0.23
0.890.86-0.580.660.65-0.580.750.70.2-0.38-0.26-0.430.650.420.020.520.880.760.760.20.880.490.54-0.65-0.34
0.820.620.060.660.940.060.90.920.38-0.40.13-0.940.880.140.310.40.80.70.890.380.80.890.89-0.1-0.39
0.760.52-0.130.650.94-0.140.950.960.49-0.220.19-0.920.940.10.420.380.760.610.870.490.760.950.96-0.2-0.22
-0.36-0.411.0-0.580.06-0.14-0.23-0.16-0.24-0.210.29-0.24-0.18-0.31-0.06-0.23-0.4-0.33-0.16-0.24-0.39-0.05-0.120.82-0.23
0.750.53-0.220.750.90.95-0.230.990.46-0.260.11-0.860.920.140.340.50.750.570.930.460.750.810.83-0.31-0.24
0.720.48-0.150.70.920.96-0.160.990.46-0.270.14-0.90.960.110.370.460.720.540.920.460.720.840.85-0.22-0.26
0.320.18-0.240.20.380.49-0.240.460.460.520.48-0.410.43-0.340.930.460.370.40.441.00.370.50.51-0.130.51
-0.34-0.34-0.22-0.38-0.4-0.22-0.21-0.26-0.270.520.130.32-0.22-0.180.46-0.3-0.26-0.21-0.240.52-0.26-0.15-0.13-0.140.99
-0.2-0.350.29-0.260.130.190.290.110.140.480.13-0.30.12-0.950.530.17-0.2-0.050.070.48-0.190.250.220.290.11
-0.59-0.33-0.24-0.43-0.94-0.92-0.24-0.86-0.9-0.410.32-0.3-0.870.04-0.39-0.31-0.57-0.45-0.83-0.41-0.57-0.87-0.85-0.090.32
0.690.45-0.180.650.880.94-0.180.920.960.43-0.220.12-0.870.140.360.290.680.530.870.430.690.840.85-0.21-0.22
0.420.5-0.310.420.140.1-0.310.140.11-0.34-0.18-0.950.040.14-0.4-0.090.420.230.16-0.340.420.050.08-0.32-0.16
0.180.03-0.060.020.310.42-0.060.340.370.930.460.53-0.390.36-0.40.470.220.260.280.930.220.470.450.150.44
0.470.43-0.230.520.40.38-0.230.50.460.46-0.30.17-0.310.29-0.090.470.450.40.370.460.450.250.26-0.1-0.29
1.00.95-0.390.880.80.76-0.40.750.720.37-0.26-0.2-0.570.680.420.220.450.930.780.371.00.70.74-0.5-0.23
0.930.92-0.320.760.70.61-0.330.570.540.4-0.21-0.05-0.450.530.230.260.40.930.680.40.930.610.64-0.44-0.19
0.780.6-0.160.760.890.87-0.160.930.920.44-0.240.07-0.830.870.160.280.370.780.680.440.780.730.75-0.31-0.21
0.320.18-0.240.20.380.49-0.240.460.461.00.520.48-0.410.43-0.340.930.460.370.40.440.370.50.51-0.130.51
1.00.94-0.390.880.80.76-0.390.750.720.37-0.26-0.19-0.570.690.420.220.451.00.930.780.370.710.74-0.5-0.23
0.70.47-0.040.490.890.95-0.050.810.840.5-0.150.25-0.870.840.050.470.250.70.610.730.50.711.0-0.1-0.15
0.740.5-0.110.540.890.96-0.120.830.850.51-0.130.22-0.850.850.080.450.260.740.640.750.510.741.0-0.18-0.14
-0.47-0.520.82-0.65-0.1-0.20.82-0.31-0.22-0.13-0.140.29-0.09-0.21-0.320.15-0.1-0.5-0.44-0.31-0.13-0.5-0.1-0.18-0.17
-0.32-0.31-0.23-0.34-0.39-0.22-0.23-0.24-0.260.510.990.110.32-0.22-0.160.44-0.29-0.23-0.19-0.210.51-0.23-0.15-0.14-0.17
Click cells to compare fundamentals

Madrigal Pharmaceuticals Account Relationship Matchups

Madrigal Pharmaceuticals fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets442.1M287.0M273.3M362.6M640.5M672.6M
Total Stockholder Equity416.6M240.0M196.1M197.4M405.3M425.6M
Common Stock Shares Outstanding15.4M15.4M16.5M17.1M18.7M19.6M
Liabilities And Stockholders Equity442.1M287.0M273.3M362.6M640.5M672.6M
Other Stockholder Equity639.6M665.4M863.5M1.2B1.7B1.8B
Total Liab25.5M47.0M77.2M165.2M235.2M247.0M
Other Current Liab23.6M44.9M54.6M91.5M89.5M93.9M
Total Current Liabilities25.1M46.6M76.8M115.9M118.5M124.5M
Property Plant And Equipment Net1.9M1.8M1.6M1.2M3.3M2.1M
Net Debt(46.0M)(53.2M)(35.5M)(281.7M)17.3M18.1M
Retained Earnings(223.2M)(425.5M)(667.3M)(962.7M)(1.3B)(1.3B)
Accounts Payable1.2M1.0M21.4M23.8M28.0M29.4M
Cash46.7M54.0M36.3M331.5M99.9M99.8M
Non Current Assets Total1.9M1.8M1.6M1.2M3.3M2.4M
Non Currrent Assets Other1.9M1.8M797K1.2M1.4M719.9K
Cash And Short Term Investments439.0M284.1M270.3M358.8M634.1M665.8M
Short Term Investments392.3M230.1M234.1M27.2M534.2M560.9M
Other Current Assets1.2M2.0M2.7M2.6M3.2M3.3M
Property Plant And Equipment Gross1.9M1.8M1.6M1.2M3.3M2.1M
Total Current Assets440.2M285.2M271.7M361.4M637.3M669.1M
Accumulated Other Comprehensive Income216K47K(80K)(32K)468K491.4K
Non Current Liabilities Total361K468K387K49.3M116.7M122.5M
Net Tangible Assets416.6M240.0M196.1M197.4M227.0M184.4M
Retained Earnings Total Equity(223.2M)(425.5M)(667.3M)(962.7M)(866.4M)(823.1M)
Capital Surpluse639.6M665.4M863.5M1.2B1.3B1.4B
Property Plant Equipment1.2M1.0M1.6M601K691.2K734.4K
Net Invested Capital416.6M240.0M196.1M246.7M520.8M358.2M
Net Working Capital415.1M238.6M194.8M245.5M518.7M356.9M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Madrigal Pharmaceuticals is a strong investment it is important to analyze Madrigal Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Madrigal Pharmaceuticals' future performance. For an informed investment choice regarding Madrigal Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Madrigal Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
For more information on how to buy Madrigal Stock please use our How to buy in Madrigal Stock guide.
You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Madrigal Pharmaceuticals. If investors know Madrigal will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Madrigal Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(25.03)
Revenue Per Share
3.705
Return On Assets
(0.52)
Return On Equity
(1.30)
The market value of Madrigal Pharmaceuticals is measured differently than its book value, which is the value of Madrigal that is recorded on the company's balance sheet. Investors also form their own opinion of Madrigal Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Madrigal Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Madrigal Pharmaceuticals' market value can be influenced by many factors that don't directly affect Madrigal Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Madrigal Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Madrigal Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Madrigal Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.